Nano-based rescue of dysfunctional autophagy in chronic obstructive lung diseases

References

• Rowe SM, Miller S, Sorscher EJ. Cystic fibrosis. N Engl J Med. 2005;352(19):1992–2001.
   PubMed Web of Science ®Google Scholar
• Ward CL, Omura S, Kopito RR. Degradation of CFTR by the ubiquitin-proteasome pathway. Cell. 1995;83(1):121–127.
   PubMed Web of Science ®Google Scholar
• Tran I, Ji C, Ni I, et al. Role of cigarette smoke-induced aggresome-formation in COPD-emphysema pathogenesis. Am J Respir Cell Mol Biol. 2015;53 (2):159–173.
   PubMed Web of Science ®Google Scholar
• Bodas M, Tran I, Vij N. Therapeutic strategies to correct proteostasis-imbalance in chronic obstructive lung diseases. Curr Mol Med. 2012;12(7):807–814.
   PubMed Web of Science ®Google Scholar
• Vij N. The case for therapeutic proteostasis modulators. Expert Opin Ther Targets. 2011;15(3):233–236.
   PubMed Web of Science ®Google Scholar
• Vij N. AAA ATPase p97/VCP: cellular functions, disease and therapeutic potential. J Cell Mol Med. 2008;12(6A):2511–2518.
   PubMed Web of Science ®Google Scholar
• De Stefano D, Villella VR, Esposito S, et al. Restoration of CFTR function in patients with cystic fibrosis carrying the F508del-CFTR mutation. Autophagy. 2014;10(11):2053–2074.
   PubMed Web of Science ®Google Scholar
• Luciani A, Villella VR, Esposito S, et al. Defective CFTR induces aggresome formation and lung inflammation in cystic fibrosis through ROS-mediated autophagy inhibition. Nat Cell Biol. 2010;12(9):863–875.
   PubMed Web of Science ®Google Scholar
• Tosco A, De Gregorio F, Esposito S, et al. A novel treatment of cystic fibrosis acting on-target: cysteamine plus epigallocatechin gallate for the autophagy-dependent rescue of class II-mutated CFTR. Cell Death Differ. 2016. [Epub ahead of print].
   Web of Science ®Google Scholar
• Pedemonte N, Lukacs GL, Du K, et al. Small-molecule correctors of defective DeltaF508-CFTR cellular processing identified by high-throughput screening. J Clin Invest. 2005;115(9):2564–2571.
   PubMed Web of Science ®Google Scholar
• Pedemonte N, Sonawane ND, Taddei A, et al. Phenylglycine and sulfonamide correctors of defective delta F508 and G551D cystic fibrosis transmembrane conductance regulator chloride-channel gating. Mol Pharmacol. 2005;67(5):1797–1807.
   PubMed Web of Science ®Google Scholar
• Varga K, Goldstein RF, Jurkuvenaite A, et al. Enhanced cell-surface stability of rescued DeltaF508 cystic fibrosis transmembrane conductance regulator (CFTR) by pharmacological chaperones. Biochem J. 2008;410(3):555–564.
   PubMed Web of Science ®Google Scholar
• Loo TW, Bartlett MC, Wang Y, et al. The chemical chaperone CFcor-325 repairs folding defects in the transmembrane domains of CFTR-processing mutants. Biochem J. 2006;395(3):537–542.
   PubMed Web of Science ®Google Scholar
• Wang Y, Bartlett MC, Loo TW, et al. Specific rescue of cystic fibrosis transmembrane conductance regulator processing mutants using pharmacological chaperones. Mol Pharmacol. 2006;70(1):297–302.
   PubMed Web of Science ®Google Scholar
• Wang Y, Loo TW, Bartlett MC, et al. Correctors promote maturation of cystic fibrosis transmembrane conductance regulator (CFTR)-processing mutants by binding to the protein. J Biol Chem. 2007;282(46):33247–33251.
   PubMed Web of Science ®Google Scholar
• Wang Y, Loo TW, Bartlett MC, et al. Additive effect of multiple pharmacological chaperones on maturation of CFTR processing mutants. Biochem J. 2007;406(2):257–263.
   PubMed Web of Science ®Google Scholar
• Wang Y, Loo TW, Bartlett MC, et al. Modulating the folding of P-glycoprotein and cystic fibrosis transmembrane conductance regulator truncation mutants with pharmacological chaperones. Mol Pharmacol. 2007;71(3):751–758.
   PubMed Web of Science ®Google Scholar
• Vij N. Synthesis and evaluation of airway targeted PLGA nanoparticles for drug delivery in obstructive lung diseases. Methods Mol Biol. 2012;906:303–310.
   PubMedGoogle Scholar
• Vij N, Min T, Bodas M, et al. Neutrophil targeted nano-drug delivery system for chronic obstructive lung diseases. Nanomedicine. 2016. [Epub ahead of print].
   PubMed Web of Science ®Google Scholar
• Vij N, Min T, Marasigan R, et al. Development of PEGylated PLGA nanoparticle for controlled and sustained drug delivery in cystic fibrosis. J Nanobiotechnol. 2010;8:22.
   PubMedGoogle Scholar
• Walworth K, Bodas M, Campbell RJ, et al. Dendrimer-based selective proteostasis-inhibition strategy to control NSCLC growth and progression. Plos One. 2016;11(7):e0158507.
   Web of Science ®Google Scholar
• Vij N. Nano-based theranostics for chronic obstructive lung diseases: challenges and therapeutic potential. Expert Opin Drug Deliv. 2011;8(9):1105–1109.
   PubMed Web of Science ®Google Scholar
• Vij N, Downey GP. The yin and yang of cystic fibrosis transmembrane conductance regulator function: implications for chronic lung disease. Am J Respir Crit Care Med. 2013;187(2):120–122.
   PubMed Web of Science ®Google Scholar
• Valle CW, Vij N. Can correcting the DeltaF508-CFTR proteostasis-defect rescue CF lung disease? Curr Mol Med. 2012;12(7):860–871.
   PubMed Web of Science ®Google Scholar
• Bodas M, Min T, Vij N. Lactosylceramide-accumulation in lipid-rafts mediate aberrant-autophagy, inflammation and apoptosis in cigarette smoke induced emphysema. Apoptosis. 2015;20:725–739.
   PubMed Web of Science ®Google Scholar
• Wiersma M, Henning RH, Brundel BJJM. Derailed proteostasis as a determinant of cardiac aging. Can J Cardiol. 2016. [Epub ahead of print].
   PubMed Web of Science ®Google Scholar
• Botti-Millet J, Nascimbeni AC, Dupont N, et al. Fine-tuning autophagy: from transcriptional to post-translational regulation. Am J Physiol Cell Physiol. 2016. ajpcell 00129 2016. [Epub ahead of print].
   PubMed Web of Science ®Google Scholar
• Dohil R, Meyer L, Schmeltzer S, et al. The effect of cysteamine bitartrate on adiponectin multimerization in non-alcoholic fatty liver disease and healthy subjects. J Pediatr. 2012;161(4):639–645 e1.
   PubMed Web of Science ®Google Scholar
• Vij N, Mazur S, Zeitlin PL. VCP is involved in ERAD and aggresome formation of ∆F508-CFTR. Pediatr Pulmonol. 2006;41(29):209.
   Google Scholar
• Balch WE, Morimoto RI, Dillin A, et al. Adapting proteostasis for disease intervention. Science. 2008;319(5865):916–919.
   PubMed Web of Science ®Google Scholar
• Mu TW, Ong DST, Wang YJ, et al. Chemical and biological approaches synergize to ameliorate protein-folding diseases. Cell. 2008;134(5):769–781.
   PubMed Web of Science ®Google Scholar
• Vij N, Fang S, Zeitlin PL. Selective inhibition of endoplasmic reticulum-associated degradation rescues {Delta}F508-cystic fibrosis transmembrane regulator and suppresses interleukin-8 levels: therapeutic implications. J Biol Chem. 2006;281(25):17369–17378.
   PubMed Web of Science ®Google Scholar
• Bodas M, Min T, Mazur S, et al. Critical modifier role of membrane-cystic fibrosis transmembrane conductance regulator-dependent ceramide signaling in lung injury and emphysema. J Immunol. 2011;186(1):602–613.
   PubMed Web of Science ®Google Scholar
• Bodas M, Min T, Vij N. Early-age-related changes in proteostasis augment immunopathogenesis of sepsis and acute lung injury. PLoS One. 2010;5(11):e15480.
   PubMed Web of Science ®Google Scholar
• Bodas M, Min T, Vij N. Critical role of CFTR-dependent lipid rafts in cigarette smoke-induced lung epithelial injury. Am J Physiol Lung Cell Mol Physiol. 2011;300(6):L811–20.
   PubMed Web of Science ®Google Scholar
• Devereux G, Fraser-Pitt D, Robertson J, et al. Cysteamine as a future intervention in cystic fibrosis against current and emerging pathogens: a patient-based ex vivo study confirming its antimicrobial and mucoactive potential in sputum. EBioMedicine. 2015;2(10):1507–1512.
   PubMed Web of Science ®Google Scholar
• Min T, Bodas M, Mazur S, et al. Critical role of proteostasis-imbalance in pathogenesis of COPD and severe emphysema. J Mol Med. 2011;89(6):577–593.
   PubMed Web of Science ®Google Scholar
• Braun AP. Cigarette smoke and calcium conspire to impair CFTR function in airway epithelia. Channels (Austin). 2014;8(3):172–173.
   PubMed Web of Science ®Google Scholar
• Courville CA, Tidwell S, Liu B, et al. Acquired defects in CFTR-dependent beta-adrenergic sweat secretion in chronic obstructive pulmonary disease. Respir Res. 2014;15:25.
   PubMed Web of Science ®Google Scholar
• Rab A, Rowe SM, Raju SV, et al. Cigarette smoke and CFTR: implications in the pathogenesis of COPD. Am J Physiol Lung Cell Mol Physiol. 2013;305(8):L530–L541.
   PubMed Web of Science ®Google Scholar
• Raju SV, Jackson PL, Courville CA, et al. Cigarette smoke induces systemic defects in cystic fibrosis transmembrane conductance regulator function. Am J Respir Crit Care Med. 2013;188(11):1321–1330.
   PubMed Web of Science ®Google Scholar
• Rasmussen JE, Sheridan JT, Polk W, et al. Cigarette smoke-induced Ca2+ release leads to cystic fibrosis transmembrane conductance regulator (CFTR) dysfunction. J Biol Chem. 2014;289(11):7671–7681.
   PubMed Web of Science ®Google Scholar
• Kopito RR, Sitia R. Aggresomes and Russell bodies. Symptoms of cellular indigestion? EMBO Rep. 2000;1(3):225–231.
   PubMed Web of Science ®Google Scholar
• Kopito RR. Aggresomes, inclusion bodies and protein aggregation. Trends Cell Biol. 2000;10(12):524–530.
   PubMed Web of Science ®Google Scholar
• Johnston JA, Ward CL, Kopito RR. Aggresomes: a cellular response to misfolded proteins. J Cell Biol. 1998;143(7):1883–1898.
   PubMed Web of Science ®Google Scholar
• Kawaguchi Y, Kovacs JJ, McLaurin A, et al. The deacetylase HDAC6 regulates aggresome formation and cell viability in response to misfolded protein stress. Cell. 2003;115(6):727–738.
   PubMed Web of Science ®Google Scholar
• Kolodziejska KE, Burns AR, Moore RH, et al. Regulation of inducible nitric oxide synthase by aggresome formation. Proc Natl Acad Sci U S A. 2005;102(13):4854–4859.
   PubMed Web of Science ®Google Scholar
• Demedts IK, Demoor T, Bracke KR, et al. Role of apoptosis in the pathogenesis of COPD and pulmonary emphysema. Respir Res. 2006;7:53.
   PubMed Web of Science ®Google Scholar
• Karrasch S, Holz O, Jorres RA. Aging and induced senescence as factors in the pathogenesis of lung emphysema. Respir Med. 2008;102(9):1215–1230.
   PubMed Web of Science ®Google Scholar
• Ito K, Barnes PJ. COPD as a disease of accelerated lung aging. Chest. 2009;135(1):173–180.
   PubMed Web of Science ®Google Scholar
• Fukuchi Y. The aging lung and chronic obstructive pulmonary disease: similarity and difference. Proc Am Thorac Soc. 2009;6(7):570–572.
   PubMedGoogle Scholar
• MacNee W, Tuder RM. New paradigms in the pathogenesis of chronic obstructive pulmonary disease I. Proc Am Thorac Soc. 2009;6(6):527–531.
   PubMedGoogle Scholar
• Bodas M, Patel N, Silverberg D, et al. Master autophagy regulator Transcription factor-EB (TFEB) regulates cigarette smoke induced autophagy-impairment and COPD-emphysema pathogenesis. Antioxid Redox Signal. 2016.
   PubMedGoogle Scholar
• Dahlmann B. Role of proteasomes in disease. BMC Biochem. 2007;8(Suppl 1):S3.
   PubMed Web of Science ®Google Scholar
• Chiti F, Dobson CM. Protein misfolding, functional amyloid, and human disease. Annu Rev Biochem. 2006;75:333–366.
   PubMed Web of Science ®Google Scholar
• Bartoszewski R, Rab A, Jurkuvenaite A, et al. Activation of the unfolded protein response by deltaF508 CFTR. Am J Respir Cell Mol Biol. 2008;39(4):448–457.
   PubMed Web of Science ®Google Scholar
• Caito S, Rajendrasozhan S, Cook S, et al. SIRT1 is a redox-sensitive deacetylase that is post-translationally modified by oxidants and carbonyl stress. FASEB J. 2010;24(9):3145–3159.
   PubMed Web of Science ®Google Scholar
• Viteri G, Carrard G, Birlouez-Aragon I, et al. Age-dependent protein modifications and declining proteasome activity in the human lens. Arch Biochem Biophys. 2004;427(2):197–203.
   PubMed Web of Science ®Google Scholar
• Deruisseau KC, Kavazis AN, Powers SK. Selective downregulation of ubiquitin conjugation cascade mRNA occurs in the senescent rat soleus muscle. Exp Gerontol. 2005;40(6):526–531.
   PubMed Web of Science ®Google Scholar
• Carrard G, Bulteau AL, Petropoulos I, et al. Impairment of proteasome structure and function in aging. Int J Biochem Cell Biol. 2002;34(11):1461–1474.
   PubMed Web of Science ®Google Scholar
• Shivalingappa PC, Hole R, Westphal CV, et al. Airway exposure to e-cigarette-vapors impairs autophagy and induces aggresome-formation. Antioxid Redox Signal. 2016;24(4):186–204.
   PubMed Web of Science ®Google Scholar
• Murakami K, Jahngen JH, Lin SW, et al. Lens proteasome shows enhanced rates of degradation of hydroxyl radical modified alpha-crystallin. Free Radic Biol Med. 1990;8(3):217–222.
   PubMed Web of Science ®Google Scholar
• Bence NF, Sampat RM, Kopito RR. Impairment of the ubiquitin-proteasome system by protein aggregation. Science. 2001;292(5521):1552–1555.
   PubMed Web of Science ®Google Scholar
• Powers ET, Morimoto RI, Dillin A, et al. Biological and chemical approaches to diseases of proteostasis deficiency. Annu Rev Biochem. 2009;78:959–991.
   PubMed Web of Science ®Google Scholar
• Vaz B, Halder S, Ramadan K. Role of p97/VCP (Cdc48) in genome stability. Front Genet. 2013;4:60.
   PubMedGoogle Scholar
• Ramadan K. p97/VCP- and Lys48-linked polyubiquitination form a new signaling pathway in DNA damage response. Cell Cycle Mar. 2012;11(6):1062–1069.
   PubMed Web of Science ®Google Scholar
• Meerang M, Ritz D, Paliwal S, et al. The ubiquitin-selective segregase VCP/p97 orchestrates the response to DNA double-strand breaks. Nat Cell Biol. 2011;13(11):1376–1382.
   PubMed Web of Science ®Google Scholar
• Ben-Zvi A, Miller EA, Morimoto RI. Collapse of proteostasis represents an early molecular event in Caenorhabditis elegans aging. Proc Natl Acad Sci U S A. 2009;106(35):14914–14919.
   PubMed Web of Science ®Google Scholar
• Bodas M, Min T, Mazur S, et al. CFTR-dependent lipid-rafts regulate ceramide signaling in chronic lung injury and emphysema. Am J Respir Crit Care Med. 2010;181:A1361.
   Web of Science ®Google Scholar
• Mizumura K, Cloonan SM, Nakahira K, et al. Mitophagy-dependent necroptosis contributes to the pathogenesis of COPD. J Clin Invest. 2014;124(9):3987–4003.
   PubMed Web of Science ®Google Scholar
• Fujii S, Hara H, Araya J, et al. Insufficient autophagy promotes bronchial epithelial cell senescence in chronic obstructive pulmonary disease. Oncoimmunology. 2012;1(5):630–641.
   PubMed Web of Science ®Google Scholar
• van Rijt SH, Keller IE, John G, et al. Acute cigarette smoke exposure impairs proteasome function in the lung. Am J Physiol Lung Cell Mol Physiol. 2012;303(9):L814–L823.
   PubMed Web of Science ®Google Scholar
• Joseph S, Pascale S, Georges K, et al. Cigarette and waterpipe smoking decrease respiratory quality of life in adults: results from a national cross-sectional study. Pulm Med. 2012;2012:868294.
   PubMedGoogle Scholar
• Rammah M, Dandachi F, Salman R, et al. In vitro cytotoxicity and mutagenicity of mainstream waterpipe smoke and its functional consequences on alveolar type II derived cells. Toxicol Lett. 2012;211(3):220–231.
   PubMed Web of Science ®Google Scholar
• Akl EA, Gaddam S, Gunukula SK, et al. The effects of waterpipe tobacco smoking on health outcomes: a systematic review. Int J Epidemiol. 2010;39(3):834–857.
   PubMed Web of Science ®Google Scholar
• Sutfin EL, McCoy TP, Reboussin BA, et al. Prevalence and correlates of waterpipe tobacco smoking by college students in North Carolina. Drug Alcohol Depend. 2011;115(1–2):131–136.
   PubMed Web of Science ®Google Scholar
• Warnakulasuriya S. Waterpipe smoking, oral cancer and other oral health effects. Evid Based Dent. 2011;12(2):44–45.
   PubMedGoogle Scholar
• Hawari FI, Obeidat NA, Ayub H, et al. The acute effects of waterpipe smoking on lung function and exercise capacity in a pilot study of healthy participants. Inhal Toxicol. 2013;25(9):492–497.
   PubMed Web of Science ®Google Scholar
• El-Zaatari ZM, Chami HA, Zaatari GS. Health effects associated with waterpipe smoking. Tob Control. 2015;24 Suppl 1:i31–i43.
   PubMed Web of Science ®Google Scholar
• Shihadeh A, Schubert J, Klaiany J, et al. Toxicant content, physical properties and biological activity of waterpipe tobacco smoke and its tobacco-free alternatives. Tob Control. 2015;24 Suppl 1:i22–i30.
   PubMed Web of Science ®Google Scholar
• Kitami MI, Kitami T, Nagahama M, et al. Dominant-negative effect of mutant valosin-containing protein in aggresome formation. FEBS Lett. 2006;580(2):474–478.
   PubMed Web of Science ®Google Scholar
• Song C, Xiao Z, Nagashima K, et al. The heavy metal cadmium induces valosin-containing protein (VCP)-mediated aggresome formation. Toxicol Appl Pharmacol. 2008;228(3):351–363.
   PubMed Web of Science ®Google Scholar
• Barnes PJ. New concepts in chronic obstructive pulmonary disease. Annu Rev Med. 2003;54:113–129.
   PubMed Web of Science ®Google Scholar
• Rangelov K, Sethi S. Role of infections. Clin Chest Med. 2014;35(1):87–100.
   PubMed Web of Science ®Google Scholar
• Rahman I, Adcock IM. Oxidative stress and redox regulation of lung inflammation in COPD. Eur Respir J. 2006;28(1):219–242.
   PubMed Web of Science ®Google Scholar
• Barnes PJ, Shapiro SD, Pauwels RA. Chronic obstructive pulmonary disease: molecular and cellular mechanisms. Eur Respir J. 2003;22(4):672–688.
   PubMed Web of Science ®Google Scholar
• Harvey CJ, Thimmulappa RK, Sethi S, et al. Targeting Nrf2 signaling improves bacterial clearance by alveolar macrophages in patients with COPD and in a mouse model. Sci Transl Med. 2011;3(78):78ra32.
   PubMed Web of Science ®Google Scholar
• Kelly JL, Bamsey O, Smith C, et al. Health status assessment in routine clinical practice: the chronic obstructive pulmonary disease assessment test score in outpatients. Respiration. 2012;84(3):193–199.
   PubMed Web of Science ®Google Scholar
• Murphy TF, Sethi S. Bacterial infection in chronic obstructive pulmonary disease. Am Rev Respir Dis. 1992;146(4):1067–1083.
   PubMed Web of Science ®Google Scholar
• Murphy TF, Sethi S, Hill SL, et al. Inflammatory markers in bacterial exacerbations of COPD. Am J Respir Crit Care Med. 2002;165(1):132.
   PubMed Web of Science ®Google Scholar
• Sethi S. Bacterial infection and the pathogenesis of COPD. Chest. 2000;117(5 Suppl 1):286S–291S.
   PubMed Web of Science ®Google Scholar
• Sethi S. Bacterial pneumonia. Managing a deadly complication of influenza in older adults with comorbid disease. Geriatrics. 2002;57(3):56–61.
   PubMedGoogle Scholar
• Sethi S, Anzueto A, Farrell DJ. Antibiotic activity of telithromycin and comparators against bacterial pathogens isolated from 3,043 patients with acute exacerbation of chronic bronchitis. Ann Clin Microbiol Antimicrob. 2005;4:5.
   PubMedGoogle Scholar
• Sethi S, Maloney J, Grove L, et al. Airway inflammation and bronchial bacterial colonization in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2006;173(9):991–998.
   PubMed Web of Science ®Google Scholar
• Sethi S, Murphy TF. Bacterial infection in chronic obstructive pulmonary disease in 2000: a state-of-the-art review. Clin Microbiol Rev. 2001;14(2):336–363.
   PubMed Web of Science ®Google Scholar
• Sethi S, Murphy TF, Klingman KL. Diagnosis, epidemiology and pathogenesis of bacterial infections in the molecular era. Clin Mol Pathol. 1996;49(1):M1–M7.
   PubMedGoogle Scholar
• Sethi S, Sethi R, Eschberger K, et al. Airway bacterial concentrations and exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2007;176(4):356–361.
   PubMed Web of Science ®Google Scholar
• Sethi S, Wrona C, Eschberger K, et al. Inflammatory profile of new bacterial strain exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2008;177(5):491–497.
   PubMed Web of Science ®Google Scholar
• Sethi SK, Khuffash F. Bacterial and viral causes of acute diarrhoea in children in Kuwait. J Diarrhoeal Dis Res. 1989;7(3–4):85–88.
   PubMedGoogle Scholar
• Veeramachaneni SB, Sethi S. Pathogenesis of bacterial exacerbations of COPD. COPD. 2006;3(2):109–115.
   PubMedGoogle Scholar
• Drannik AG, Pouladi MA, Robbins CS, et al. Impact of cigarette smoke on clearance and inflammation after Pseudomonas aeruginosa infection. Am J Respir Crit Care Med. 2004;170(11):1164–1171.
   PubMed Web of Science ®Google Scholar
• Janen SB, Chaachouay H, Richter-Landsberg C. Autophagy is activated by proteasomal inhibition and involved in aggresome clearance in cultured astrocytes. Glia. 2010;58(14):1766–1774.
   PubMed Web of Science ®Google Scholar
• Bhattacharya A, Eissa NT. Autophagy and autoimmunity crosstalks. Front Immunol. 2013;4:88.
   PubMed Web of Science ®Google Scholar
• Boutou AK, Raste Y, Reid J, et al. Does a single Pseudomonas aeruginosa isolation predict COPD mortality? Eur Respir J. 2014;44(3):794–797.
   PubMed Web of Science ®Google Scholar
• Ni I, Ji C, Vij N. Second-hand cigarette smoke impairs bacterial phagocytosis in macrophages by modulating CFTR dependent lipid-rafts. Plos One. 2015;10(3):e0121200.
   PubMed Web of Science ®Google Scholar
• Bodas M, Thompson-Carpenter R, Mohanty D, et al. Nicotine exposure induces bronchial epithelial cell apoptosis and senescence via ROS mediated autophagy-impairment. Free Radic Biol Med. 2016;97:441–453..
   Web of Science ®Google Scholar
• Luciani A, Villella VR, Esposito S, et al. Cystic fibrosis: a disorder with defective autophagy. Autophagy. 2011;7(1):104–106.
   PubMed Web of Science ®Google Scholar
• Accurso FJ, Rowe SM, Clancy JP, et al. Effect of VX-770 in persons with cystic fibrosis and the G551D-CFTR mutation. N Engl J Med. 2010;363(21):1991–2003.
   PubMed Web of Science ®Google Scholar
• Maiuri L, De Stefano D, Raia V, et al. The holy grail of cystic fibrosis research: pharmacological repair of the F508del-CFTR mutation. Ann Transl Med. 2015;3(Suppl 1):S24.
   PubMedGoogle Scholar
• Clancy JP, Rowe SM, Accurso FJ, et al. Results of a phase IIa study of VX-809, an investigational CFTR corrector compound, in subjects with cystic fibrosis homozygous for the F508del-CFTR mutation. Thorax. 2012;67(1):12–18.
   PubMed Web of Science ®Google Scholar
• Vij N. Editorial: Proteostasis-imbalance and pathogenesis of chronic obstructive lung diseases. Curr Mol Med. 2012;12(7):805–806.
   PubMed Web of Science ®Google Scholar
• Churg A, Sin DD, Wright JL. Everything prevents emphysema: are animal models of cigarette smoke-induced COPD any use? Am J Respir Cell Mol Biol. 2011;45:1111–1115.
   PubMed Web of Science ®Google Scholar
• Teramoto S, Ishii M. Aging, the aging lung, and senile emphysema are different. Am J Respir Crit Care Med. 2007;175(2):197-8; author reply 198.
   PubMed Web of Science ®Google Scholar
• MacNee W. Accelerated lung aging: a novel pathogenic mechanism of chronic obstructive pulmonary disease (COPD). Biochem Soc Trans. 2009;37(Pt 4):819–823.
   PubMed Web of Science ®Google Scholar
• Tsuji T, Aoshiba K, Nagai A. Alveolar cell senescence in patients with pulmonary emphysema. Am J Respir Crit Care Med. 2006;174(8):886–893.
   PubMed Web of Science ®Google Scholar
• Tuder RM, Kern JA, Miller YE. Senescence in chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2012;9(2):62–63.
   PubMedGoogle Scholar
• Tran I, Ji C, Ni I, et al. Role of cigarette smoke-induced aggresome formation in chronic obstructive pulmonary disease-emphysema pathogenesis. Am J Respir Cell Mol Biol. 2015;53(2):159–173.
   PubMed Web of Science ®Google Scholar